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a b s t r a c t
Mammalian cells activate DNA damage response pathways in response to virus infections. Activation of
these pathways can enhance replication of many viruses, including herpesviruses. Activation of cellular
ATM results in phosphorylation of H2AX and recruits proteins to sites of DNA damage. We found that
varicella-zoster (VZV) infected cells had elevated levels of phosphorylated H2AX and phosphorylated
ATM and that these levels increased in cells infected with VZV deleted for ORF61 or ORF63, but not
deleted for ORF67. Expression of VZV ORF61, ORF62, or ORF63 alone did not result in phosphorylation of
H2AX. While BGLF4, the Epstein-Barr virus homolog of VZV ORF47 protein kinase, phosphorylates H2AX
and ATM, neither VZV ORF47 nor ORF66 protein kinase phosphorylated H2AX or ATM. Cells lacking ATM
had no reduction in VZV replication. Thus, VZV induces phosphorylation of H2AX and ATM and this effect
is associated with the presence of speciﬁc VZV genes in virus-infected cells.
Published by Elsevier Inc.
Introduction
DNA damage is induced by numerous stresses to the cell, including
ionizing radiation, ultraviolet (UV) radiation, cytotoxic drugs, telomere
shortening, programmed breaks (e.g. V(D)J recombination), class
switch recombination, and replication stress associated with virus
infections (Bonner et al., 2008; Burhans and Weinberger, 2007). Cells
respond to DNA damage by activating checkpoint pathways that delay
the progression through the cell cycle, promote DNA repair, or induce
cell repair (Garner and Costanzo, 2009). Double-stranded DNA breaks
are sensed by the MRN complex which results in recruitment and
phosphorylation of the tranducers of the DNA damage response, the
PI3-kinase-like kinases: ataxia telangiectasia mutated (ATM), ataxia
telangiectasia and Rad3-related (ATR), and DNA-dependent protein
kinase (DNA-PK) (reviewed in Weitzman et al., 2010). ATM is
phosphorylated at serine 1981 (Bakkenist and Kastan, 2003; Lee and
Paull, 2005; Carson et al., 2003; Uziel et al., 2003) which in turn
phosphorylates many downstream proteins involved in coordinating
cell cycle arrest, DNA repair and apoptosis such as H2AX, Mdc1, Nbs1,
Chk2, 53BP1, and p53 (Bartek and Lukas, 2003).
H2AX is a member of the histone family which interacts with
eukaryotic DNA and helps to regulate transcription. H2AX is
phosphorylated on serine 139 to form γ-H2AX at sites of double-
stranded DNA breaks, where proteins involved in DNA repair
accumulate (Rogakou et al., 1999; Bonner et al., 2008). Phosphor-
ylation of H2AX also occurs with other stimuli including single-
stranded DNA breaks induced by ultraviolet radiation and with the
normal progression through the cell cycle (Ichijima et al., 2005).
Virus replication presents the host cells with foreign DNA,
including free DNA ends and unusual DNA structures. Thus, virus
replication induces DNA damage responses which can result in
apoptosis as a host defense mechanism against infection
(Chaurushiya and Weitzman, 2009). Viruses have evolved a variety
of mechanisms to counteract DNA damage responses to enhance
replication and persistent infection. Many DNA viruses initially
activate the DNA damage response pathway and then subse-
quently inhibit it (reviewed in Chaurushiya and Weitzman, 2009;
Turnell and Grand, 2012; Weitzman et al., 2010). Adenovirus
proteins E1B and E4 inhibit the MRN complex (Stracker et al.,
2002), while herpes simplex virus (HSV) UL12 associates with the
MRN complex and likely facilitates its activity (Balasubramanian
et al., 2010). Kaposi sarcoma associated herpesvirus (KSHV) vIRF1
(Shin et al., 2006) and Epstein-Barr virus (EBV) LMP1 (Ma et al.,
2011) inhibit ATM, while HSV ICP0 (Li et al., 2008) and cytome-
galovirus IE1 (Castillo et al., 2005) activate ATM. EBV BGLF4 (Li
et al., 2011) and KSHV v-cyclin (Koopal et al., 2007) activate H2AX.
The human alphaherpesvirus consist of HSV-1, HSV-2, and
varicella-zoster virus (VZV). These viruses cause lytic infections
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in epithelial cells and latent infections in neurons of sensory
ganglia. HSV and VZV have similar mechanisms of replication in
the cell and the seven proteins required for origin-dependent
replication of HSV DNA (Challberg, 1986) have orthologs in VZV.
HSV and VZV infection of cells brings linear viral DNA with free
ends into the cell that resemble double-stranded DNA breaks, as
well as nicked viral DNA which has single-stranded DNA breaks.
Thus, HSV and VZV infection would be expected to result in
activation of the DNA damage response. HSV infection of cells
results in replication compartments which contain both viral
proteins (ICP8, viral DNA polymerase [Bush et al., 1991; Quinlan
et al., 1984]) as well as host cell proteins important for the DNA
damage response (Nbs1, Mre11, Rad50, and phosphorylated ATM
[Gregory and Bachenheimer, 2008; Lilley et al., 2005; Shirata et al.,
2005]). γ-H2AX accumulates in areas surrounding HSV replication
complexes (Wilkinson and Weller, 2006). HSV infection results in
phosphorylation of other proteins involving the DNA damage
response including Nbs1, Chk2, 53BP1, and p53 (Gregory and
Bachenheimer, 2008; Lilley et al., 2005; Shirata et al., 2005). While
many studies have evaluated the interaction of HSV with DNA
damage responses, none have evaluated VZV. Therefore, we
studied the effects on VZV infection on activation of cellular
proteins involved in the DNA damage response.
Results
Infection with VZV induces phosphorylation of H2AX in melanoma
cells and ﬁbroblasts, but not in U2OS cells
HSV-2 has previously reported to induce phosphorylation of
H2AX in Vero cells (Wilkinson and Weller, 2006). Therefore we
analyzed the effect of VZV infection on H2AX. We found that VZV,
like HSV-2, induced phosphorylation of H2AX in melanoma cells
(Fig. 1A) or human diploid ﬁbroblasts (Fig. 1B); however, the level
of total H2AX was unchanged in virus-infected cells. Phosphoryla-
tion of H2AX was about 2-fold higher in melanoma cells and
5-fold higher in human diploid ﬁbroblasts infected with cell-
associated VZV ROka than in mock-infected cells. UV-irradiated
cells (Fig. 1, lane 1) served as a positive control for phosphoryla-
tion of H2AX. A similar increase in phosphorylation of H2AX
(4-fold) was observed with parental (wild-type) VZV Oka in
human diploid ﬁbroblasts compared with mock-infected cells
(data not shown). HSV-2 infection also induced phosphorylation
of H2AX in melanoma cells and human diploid ﬁbroblasts.
High levels of phosphorylated H2AX are induced in melanoma cells
and ﬁbroblasts after infection with VZV deleted for ORF61 or ORF63,
but not deleted for ORF67
Prior studies showed that immediate-early genes of HSV are
important in initiating the DNA damage response in HSV-infected
cells (Chenet-Monte et al., 1986; Johnson et al., 1992; Peat and
Stanley, 1986). Therefore we tested two VZV mutants with dele-
tions, one with a deletion in an immediate-early gene (VZV ORF63)
and one with a deletion in a gene homologous to the HSV ICP0
immediate-early gene (VZV ORF61). γ-H2AX levels were 1.6-fold
higher in melanoma cells infected with ROka61D (deleted for VZV
ORF61) compared with ROka, and 1.7-fold higher in melanoma
cells infected ROka63D (deleted for VZV ORF63) than ROka
(Fig. 1A). Cells infected with rescued viruses (ROka61DR and
ROka63DR) had levels of γ-H2AX closer to ROka. Similar increases
in γ-H2AX were also observed in ﬁbroblasts infected with
ROka61D and ROka63D (Fig. 1B) and in 293T cells (data not
shown).
U2OS osteosarcoma cells complement the growth of VZV
deleted for ORF61 (ROka61D [Cohen and Nguyen, 1998]) and
ORF63 (ROka63D [Ambagala and Cohen, 2007]). Therefore, we
determined whether phosphorylation of H2AX might be different
in ROka63D or ROka61D-infected U2OS cells than in melanoma
cells. Levels of γ-H2AX in U2OS were constitutively elevated in the
presence or absence of virus infection and at levels similar to the
UV irradiated cells (Fig. 1C); therefore, we could not assess the
effect of deletion of ORF61 or ORF63 on γ-H2AX in U2OS cells.
Since deletion VZV ORF61 or ORF63 from VZV increased levels
of γ-H2AX; we determined whether ORF61 and ORF63 proteins
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Fig. 1. Immunoblot of γ-H2AX and H2AX expression in melanoma (MeWo) cells
(A), human diploid ﬁbroblasts (MRC-5 cells) (B) and U2OS osteosarcoma cells
(C) infected with wild-type VZV, VZV mutants, and HSV-2. MeWo, MRC-5 and U2OS
cells were infected with 1106 PFU of cell-associated VZV (ROka, ROka61D,
ROka61DR, ROka63D, or ROka63DR) or with HSV-2 at an MOI of 0.5. At 48 h after
infection with VZV (or 24 h after with HSV-2), the cells were lysed and equivalent
amounts of cell lysates were immunoblotted with anti-γ-H2AX, anti-H2AX, and
anti-VZV gE antibody. The numbers below the H2AX panels indicate the ratio of
intensity of the γ-H2AX and H2AX bands in infected cell lysates divided by the ratio
of the intensity of the γ-H2AX and H2AX bands in mock-infected cells. Densito-
metry was performed using Image J software. UV indicates cells that were treated
with 50 mJ/cm2 of UV irradiation and 14 h later lysates were prepared. The
experiments were repeated and similar results were obtained.
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could directly block phosphorylation of H2AX. Melanoma cells
were transfected with plasmids expressing VZV ORF61, ORF62, or
ORF63, and γ-H2AX was detected on immunoblot. Levels of
γ-H2AX were similar in cells expressing VZV ORF61 protein,
IE62, or IE63 compared with vector control cells (Fig. 2A). Similar
results were observed in 293T cells (data not shown). Since ORF61
protein is required for nuclear localization of IE63 in some cell
types (Walters et al., 2008), we contransfected cells with plasmids
expressing ORF61 and ORF63. Levels of γ-H2AX were comparable
in cells expressing both VZV ORF61 protein and IE63, or in cells
expressing both IE62 and IE63 compared with vector control cells
(Fig. 2B). Thus, while VZV deleted for ORF61 or ORF63 induces
high levels of phosphorylated H2AX, expression of VZV ORF61 or
ORF63 alone is unable to inhibit phosphorylation of H2AX in cells.
Since the increased level of phosphorylated H2AX in cells
infected with ROka61D or ROka63D, relative to wild-type virus,
may have been due to a higher titer of inoculum of the mutant
viruses used in order to obtain a similar level of infection, we next
compared levels of phosphorylated H2AX in cells infected with
another VZV mutant. VZV ORF67D is deleted for VZV glycoprotein
I, and grows to peak titers about 1 log lower than parental virus
which is similar to the reduction in peak titers seen with ROka61D
and ROka63D (Cohen et al., 2004; Cohen and Nguyen, 1997, 1998).
Infection of melanoma cells with ROka67D resulted in similar
levels of γ-H2AX as were seen in cells infected with ROka (Fig. 3).
Thus, the increased level of phosphorylated H2AX in cells infected
with ROka61D or ROka63D was not solely due to impaired growth
of the virus in melanoma cells.
ATM is activated in melanoma cells after infection with VZV, and
higher levels of activated ATM are observed in cells deleted for ORF61
or ORF63, but not deleted for ORF67
The ATM protein kinase is phosphorylated in response to DNA
damage and accumulates at sites of single- and double-stranded
DNA breaks (Garner and Costanzo, 2009). Since infection of cells
with HSV induces phosphorylation of ATM (Shirata et al., 2005),
we determined whether VZV infection also results in phosphor-
ylation of ATM. Infection of melanoma cells with VZV or HSV
induced phosphorylation of ATM (Fig. 4A). A chloroquine treated
lymphoblastoid cell line served as a positive control for phosphor-
ylation of ATM (Goldstine et al., 2006). Melanoma cells infected
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Fig. 2. γ-H2AX levels in cells transfected with plasmids expressing VZV ORF61, ORF62, and ORF63. (A) MeWo cells were transfected with 4 μg of plasmid DNAs (pCMV-61,
pCMV-62, pCI-63 and pMax-GFP) using Lipofectamine 2000. Two days after transfection, the cells were harvested and lysed, and the clariﬁed lysate was immunoblotted with
antibodies to γ-H2AX, H2AX, ORF61 protein, IE62, IE63, and β-actin. The experiment was repeated with similar results. (B) MeWo cells were cotransfected with 5 μg of
plasmid DNAs (pCMV-61 and pCI-63, pCMV-62 and pCI-63 or with pMax-GFP) using Lipofectamine 2000 and processed as described in panel A. The transfection efﬁciency
for melanoma cells was 20% based on GFP expression. The numbers below the H2AX panels indicate the ratio of intensity of the γ-H2AX and H2AX bands in cells
transfected with plasmids expressing VZV proteins divided by the ratio of the intensity of the γ-H2AX and H2AX bands in cells transfected with plasmid expressing GFP.
Densitometry was performed using Image J software. The experiment was repeated with similar results.
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Fig. 3. Immunoblot of γ-H2AX and H2AX expression in melanoma (MeWo) cells
infected with wild-type VZV or VZV deleted for ORF67 (ROka67D). MeWo cells
were infected with ROka or ROka67D and 48 h after infection, the cells were lysed
and equivalent amounts of cell lysates were immunoblotted with anti-γ-H2AX,
anti-H2AX, anti-VZV IE63, and anti-VZV gE antibody. The numbers below the H2AX
panels indicate the ratio of intensity of the γ-H2AX and H2AX bands in infected cell
lysates divided by the ratio of the intensity of the γ-H2AX and H2AX bands in
mock-infected cells. Densitometry was performed using Image J software. The
experiment was repeated with similar results.
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with VZV deleted for ORF61 or ORF63 showed a marked increase
in phosphorylated ATM compared to cells infected with wild-type
VZV, while cells infected with rescued viruses (ROka61DR and
ROka63DR) had levels of phosphorylated ATM closer to ROka.
Infection of U2OS cells by VZV deleted for ORF61 or ORF63, or by
HSV-2 did not result in increased phosphorylation of ATM
(Fig. 4B). Melanoma cells infected with VZV deleted for ORF67
did not show an increase in phosphorylated ATM compared with
cells infected with parental VZV (Fig. 5).
VZV ORF47 and ORF66 protein kinases do not phosphorylate H2AX
or ATM
To determine whether phosphorylation of H2AX is induced by VZV
protein kinases, we transfected 293T cells with plasmids expressing
GFP, VZV ORF47, ORF66, or the combination of ORF47 and ORF66
together and immunoblotted for γ-H2AX, phosphorylated ATM, or the
V5 epitope tag that was fused to the viral protein kinases. Although
the protein kinases were expressed in the cells, neither individual VZV
protein kinase nor the combination of both protein kinases induced
phorphorylation of H2AX (Fig. 6A).
The EBV BGLF4 protein kinase induces phosphorylation of ATM
and H2AX (Li et al., 2011; Tarakanova et al., 2007), and its
orthologs in HSV and VZV are UL13 and ORF47, respectively.
293T cells were transfected with GFP, HSV UL13, EBV BGLF4, or
the two VZV protein kinases. Each of the protein kinases were
expressed in transfected 293T cells; however, only EBV BGLF4 and
neither HSV UL13 nor the VZV protein kinases induced phosphor-
ylation of ATM (Fig. 6B). As a control, the V5 epitope tagged VZV
proteins were immunoprecipitated and protein kinase assays
showed that ORF47 and ORF66 proteins could autophosphorylate
(while the ORF13 thymidylate synthetase protein could not
autophosphorylate), indicating that the epitope tag did not inter-
fere with the kinase activity of the VZV proteins (Fig. 6C).
VZV is not impaired for growth in ﬁbroblasts lacking ATM
To determine if ATM has an important role in VZV replication,
we infected human ﬁbroblasts from healthy persons or patients
with ataxia telangiectasia (with mutations in ATM) with VZV and
HSV-2 and measured the titer of virus over time. Growth of VZV
(Fig. 7A) or HSV-2 (Fig. 7B) was not impaired in ﬁbroblasts with
mutations in ATM compared to wild-type ﬁbroblasts. Similar
results were seen with another ATM deﬁcient cell line (data not
shown). Thus, ATM is not critical for growth of VZV in vitro.
Discussion
We found that infection of cells with VZV, as well as HSV,
induces the phosphorylation of H2AX in melanoma cells and
ﬁbroblasts, but not in U2OS cells. U2OS had constitutively high
levels of γ-H2AX that were not increased after virus infection.
Unlike many transformed cell lines, U2OS cells have wild-type p53
and retinoblastoma genes (Yao and Schaffer, 1995). U2OS cells are
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Fig. 4. Immunoblot of phosphorylated-ATM and ATM expression in melanoma
(MeWo) cells (A) and U2OS osteosarcoma cells (B) infected with wild-type or
mutant VZV or HSV-2. Cells were infected with 1106 PFU of cell-associated VZV
ROka, ROka61D, ROka61DR, ROka63D, ROka63DR, or infected with HSV-2 at an MOI
of 0.5. At 48 h after infection (or 24 h after infection in HSV-2), the cells were lysed
and equal amounts of clariﬁed lysates were immunoblotted with anti-phosphory-
lated-ATM (Ser1981), ATM, VZV gE, and HSV gD. The numbers below the ATM
panels indicate the ratio of intensity of the phosphorylated ATM and ATM bands in
infected cell lysates divided by the ratio of the intensity of the phosphorylated-ATM
and ATM bands in mock-infected cells. Densitometry was performed using Image J
software. A chloroquine (ChQ) treated lymphoblastoid cell line (LCL) was a positive
control for phosphorylation of ATM. The experiments were repeated with similar
results.
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Fig. 5. Immunoblot of phosphorylated ATM and total ATM expression in melanoma
(MeWo) cells infected with wild-type VZV or VZV deleted for ORF67 (ROka67D).
MeWo cells were infected with ROka or ROka67D and 48 h after infection, the cells
were lysed and equivalent amounts of cell lysates were immunoblotted with anti-
phosphorylated ATM, anti-ATM, or anti-VZV IE63 antibody. The numbers below the
ATM panels indicate the ratio of intensity of the phosphorylated ATM and ATM
bands in infected cell lysates divided by the ratio of the intensity of the
phosphorylated ATM and ATM bands in mock-infected cells. Densitometry was
performed using Image J software. The experiment was repeated with similar
results.
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defective either for chromatin-dependent nuclear repression or for
a signal transduction pathway that activates nuclear repression in
response to virus infection (Hancock et al., 2006). Thus, U2OS cells
likely have additional properties that result in constitutive phos-
phorylation of H2AX.
Infection of melanoma cells and ﬁbroblasts with VZV deleted
for VZV ORF61 or ORF63 induced higher levels of γ-H2AX than
infection with wild-type virus. However, transient transfection of
cells with either of these viral proteins had no discernable effect
on the level of phosphorylated H2AX. These results indicate that
ORF61 or ORF63 affect phosphorylation of H2AX only in the
context of virus infection. VZV ORF61 and ORF63 have several
properties in common including (a) regulation of expression of
other viral proteins (Bontems et al., 2002; Moriuchi et al., 1993),
(b) importance for optimal virus replication in vitro (Cohen and
Nguyen, 1998; Cohen et al., 2004), and (c) complementation of
growth of viral mutants in these genes by U2OS cells (Cohen and
Nguyen, 1998; Ambagala and Cohen, 2007). Unlike the increase in
γ-H2AX levels observed in melanoma cells and ﬁbroblasts with the
VZV mutants, no increase was observed in U2OS cells.
The increased levels of γ-H2AX were observed in cells infected
with ROka61D or ROka63D compared to the wild-type virus which
could have been due to their impaired replication in melanoma
cells. To obtain a similar level of replication we used a larger
infected cell inoculum of ROka61D or ROka63D than for wild-type
virus. However, the larger inoculum of the VZV mutant virus
infected cells (containing more viral DNA and more free DNA ends)
does not alone account for the increased level of γ-H2AX, since
cells infected with ROka67D which is similarly impaired for
growth in melanoma cells did not show higher levels of γ-H2AX
than cells infected with parental virus.
Neither the VZV ORF47 or ORF66 protein kinases nor the
combination of the two were able to phosphorylate γ-H2AX or
ATM. Previously Li et al. (2011) showed that the EBV BGLF4 protein
kinase phosphorylates ATM. Tarakanova et al. (2007) showed that
EBV BGLF4 and murine γ-herpesvirus 68 (MHV68) ORF36 protein
phosphorylate H2AX. While EBV BGLF4 is the ortholog of VZV
ORF47 and HSV UL13, and although the EBV BGLF4 protein kinase
shares a number of protein substrates with the HSV UL13 protein
kinase, neither VZV ORF47 nor HSV UL13 protein kinases phos-
phorylated ATM. Phosphorylation of ATM was induced in cells
infected with VZV or HSV. Phosphorylated ATM accumulates
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Fig. 7. Growth of VZV ROka or HSV-2 in wild-type and ataxia telangiectasia mutant
(ATM) ﬁbroblasts. VZV ROka (A) or HSV-2 (B) was used to infect wild-type (GM07667)
or ATM mutant (GM02530) ﬁbroblasts for various periods of time. VZV infections were
performed with cell-associated virus containing 250 PFU added to 106 cells; HSV
infections were performed with 30,000 PFU of cell-free virus added to 3105 cells
(MOI 0.1). At various days after infection the monolayers were treated with trypsin and
infected cells were titrated onto melanoma cells. Error bars show standard error. The
experiment in panel A with VZV was repeated with similar results.
T. Yamamoto et al. / Virology 452-453 (2014) 52–5856
directly at sites of HSV replication (Lilley et al., 2005; Shirata et al.,
2005; Gregory and Bachenheimer, 2008).
Growth of VZV and HSV was unchanged in ﬁbroblasts lacking
ATM compared with wild-type cells. HSV-1 was impaired for
replication in ATM-deﬁcient cells when infected at a low MOI
(Lilley et al., 2005), while HSV-2 was not impaired at high or low
MOI (Shirata et al., 2005). Since we infected cells with cell-
associated VZV, this likely corresponds to a high MOI for the
uninfected cell that contacts a virus-infected cell in the inoculum.
Thus, the lack of effect on VZV replication in ATM null cells may
have been due to the relatively high MOI used. HSV infection of
ATM-deﬁcient cells failed to induce phosphorylation of a member
of the MRN complex (Nbs1), Chk2, and p53 indicating that the
DNA damage response requires activation of ATM in HSV infected
cells (Lilley et al., 2005; Shirata et al., 2005). Interestingly, while
ATM is not needed for replication of MHV68 in mouse ﬁbroblasts,
ATM is required for efﬁcient replication of MHV68 in mouse
macrophages (Tarakanova et al., 2007). Thus, while we did not
observe a difference in VZV replication in ﬁbroblasts lacking ATM,
ATM might be important for VZV replication in other cell types.
In summary, we found that melanoma cells infected with VZV
have elevated levels of phosphorylated H2AX and phosphorylated
ATM, and that levels of both of these phosphoproteins increased in
cells infected with VZV deleted for ORF61 or ORF63, but not
deleted for ORF67. Thus, the level of phosphorylation of H2AX and
ATM is associated with the presence of speciﬁc VZV genes.
Materials and methods
Cells and viruses
MeWo cells (human melanoma cells provided by Charles Grose,
University of Iowa) and MRC-5 cells (human diploid ﬁbroblasts from
the American Type Culture Collection, Manassas, VA) were maintained
inminimal essential medium and supplemented with 10% fetal bovine
serum (FBS). U2OS cells (human osteosarcoma cells from the Amer-
ican Type Culture Collection) were maintained in Dulbecco0s modiﬁed
Eagle0s medium. Human ﬁbroblasts with a mutation in ATM
(GM02530) or from a healthy donor (GM07667) were obtained from
the Coriell Institute for Medical Research, Camden, New Jersey, and
were grown in media recommended by Coriell. Recombinant Oka VZV
(ROka) was obtained from cosmid clones derived from the Oka
vaccine strain of VZV (Cohen and Seidel, 1993). VZV ROka61D
(Cohen and Nguyen, 1998), ROka63D (Cohen et al., 2004), and
ROka67D (Cohen and Nguyen, 1997) have ORF61, ORF63, and ORF67
deleted, respectively, and ROka61DR and ROka63DR are rescued
viruses that express ORF61 and ORF63 proteins. HSV-2 strain 333
was obtained from Gary Hayward. VZV and HSV-2 were propagated
and titrated in MeWo and Vero cells, respectively.
Plasmids and transient-transfection assays
Plasmids pCMV61 (Moriuchi et al., 1994), pCMV62 (Moriuchi
et al., 1994), and pCI63 (Ambagala et al., 2009) containing the
coding region of VZV ORF61, 62 and 63, respectively, under the
control of IE promoter of human cytomegalovirus were used for
transfections. Plasmids containing VZV ORF47 and HSV-1 UL13,
which have a carboxyl terminal V5 epitope tag from the P and V
genes of SV5 paramyxovirus, inserted into the multiple cloning site
of pcDNA3.1 (Invitrogen) were described previously (Liu et al.,
2008, 2012). Plasmids expressing VZVORF66 and EBV BGLF4,
containing carboxyl terminal V5 epitope tags, were constructed
similarly. Plasmid pmaxGFP (Amaxa, Gaithersburg, MD) was used
as a control for transient transfections. MeWo cells, grown in six-
well plates, were transfected with 4 μg of plasmid DNA using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the
manufacturer0s instructions. Two days after transfection, the cells
were harvested and lysed, and immunoblots were performed.
Immunoblots and antibodies
MeWo, MRC-5 and U2OS cells in six well plates were inocu-
lated with VZV-infected cells containing 1106 PFU of ROka,
ROka61DR, or ROka63DR virus or with HSV-2 at an MOI of 0.5.
For infections with VZV mutants impaired for growth (ROka61D,
ROka63D, and ROka67D) the amount of infected cells used was
titrated so that the level of infection (as measured by gE) would be
similar to parental virus as described previously (Hoover et al.,
2006). VZV- or HSV-infected cells were harvested 48 or 24 h after
infection, respectively. Cells were lysed in either 1% CHAPS (3-[(3-
cholamidopropyl)-dimethylammonio]-1-propanesulfonate, T. J.
Baker, Phillipsburg, NJ) in Tris–buffered saline (19.98 mM Tris,
136 mM NaCl, pH 7.4) or in RIPA buffer (10 mM Tris–HCl, pH 8.0,
100 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.5% deoxycholate,
and 0.5% sodium dodecyl sulfate (SDS)) supplemented with
complete protease inhibitor cocktail (Roche Applied Science,
Indianapolis, IN) for 30 min on ice. After centrifugation at
17,900g the supernatant was boiled for 5 min in 1 SDS–poly-
acrylamide gel electrophoresis loading buffer. Equivalent amounts
of cell lysates (5 cm2 of infected cells for blotting cellular proteins
and 2 cm2 for viral proteins) were separated on 6% or 4–20%
Tris–glycine SDS–polyacrylamide gels (Invitrogen), transferred to
nitrocellulose membranes (Whatman, Sanford, ME) and incubated
with antibodies to H2AX (GeneTex, Irvine, CA), γ-H2AX–Ser139 (Milli-
pore, Billerica, MA), phosphorylated ATM–Ser1981 (Epitomics, Burlin-
game, CA) or ATM (Cell Signaling Technology, Beverly, MA), VZV
ORF61, ORF62, or ORF63 protein (Ng et al., 1994) or β-actin (Sigma-
Aldrich, St. Louis, MO). After incubation with horseradish peroxidase-
conjugated goat anti-rabbit or anti-mouse antibodies (Thermo Scien-
tiﬁc, Rockford, IL), immunoreactive bands were visualized by Super-
Signal West Pico or Dura Chemiluminescent Substrate (Thermo
Scientiﬁc). The intensity of bands was quantiﬁed using NIH Image J
software (http://rsb.info.nih.gov/ij/).
Immunoprecipitations and kinase assays
HEK293T cells in six well plates were transfected with 2 μg of
plasmids expressing VZV ORF47, ORF66, or ORF13 (Liu et al., 2008)
and 2 days later, the cells were lysed in RIPA buffer (0.01 M Tris
HCl [pH 7.4], 0.15 M NaCl, 1% Triton X-100, 1% deoxycholate, and
0.1% SDS) with complete protease inhibitors (Clontech) and 1 mM
sodium vanadate to inhibit phosphatases. Immune complexes
were immunoprecipitated using 20 μl anti-V5 agarose beads
(Invitrogen) for 1 h at 4 1C. After washing twice in RIPA buffer
and twice in protein kinase buffer (Cell Signaling Technology), the
immune complexes were resuspended in 50 μl of protein kinase
buffer with 1 mM spermidine (Sigma) and 1 μCi of γ32P ATP. The
immune complexes were incubated at 30 1C for 1 h and washed
twice with kinase buffer and twice with RIPA buffer, and resus-
pended in 50 μl SDS protein gel loading solution (Quality Biologi-
cal) containing 10% β-mercaptoethanol, boiled for 5 min and
subjected to electrophoresis on a 4–20% PAGE gel. The gel was
dried and autoradiography was performed.
Measurement of virus replication
Human ﬁbroblasts in 25 cm2 ﬂasks were infected with 250 PFU
of cell-associated VZV or 30,000 of PFU cell-free of HSV (MOI of
0.1). At various times after infection, the VZV monolayers were
treated with trypsin and serial dilutions of infected cells were used
to infect melanoma cells. One week later the plates were stained
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with crystal violet and the number of plaques was counted. Flasks
containing HSV-infected cells were scraped, freeze thawed three
times and aliquots were used to infect Vero cells. After 1 h, the
media was replaced with media containing 0.5% human immuno-
globulin (Baxter Healthcare Corporation, Westlake Village, CA),
and plaques were stained and counted 2 days later.
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